Neuroprotective actions of peripherally administered insulin-like growth factor I in the injured olivo-cerebellar pathway

European Journal of Neuroscience

Volumn 11, Issue 6, 1999, Pages 2019-2030

  Fernandez, A M ^a   De La Vega, A Gonzalez ^a   Planas, B ^a   Torres Aleman, I ^a  

^a INSTITUTO CAJAL   (Spain)

Author keywords

Ataxia; Insulin like growth factor I; Neurodegeneration; Neuronal plasticity; Neuroregeneration; Neurotrophic actions; Rat

Indexed keywords

3 ACETYLPYRIDINE; 4 AMINOBUTYRIC ACID; CALBINDIN; GLUTAMATE RECEPTOR; GLUTAMIC ACID; NERVE CELL ADHESION MOLECULE; NEUROMODULIN; PROTEIN BCL 2; SOMATOMEDIN C;

ANIMAL EXPERIMENT; ARTICLE; ASTROCYTE; CEREBELLUM CORTEX; DEAFFERENTATION; INFERIOR OLIVE; MALE; MOTOR PERFORMANCE; NEUROPROTECTION; NONHUMAN; OLIVOPONTOCEREBELLAR ATROPHY; PRIORITY JOURNAL; RAT;

ANIMALS; ATAXIA; CEREBELLUM; DENERVATION; HUMANS; INJECTIONS, INTRAVENTRICULAR; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; MALE; NERVE REGENERATION; NEURAL PATHWAYS; NEUROPROTECTIVE AGENTS; NEUROTOXINS; OLIVARY NUCLEUS; PYRIDINES; RATS; RATS, WISTAR; RECOMBINANT PROTEINS; SOMATOMEDINS;

EID: 0033046355     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9568.1999.00623.x     Document Type: Article

References (12)

1. Auletta, M., Nielsen, F.C. & Gammeltoft, S. (1992) Receptor mediated endocytosis and degradation of insulin-like growth factor I and II in neonatal rat astrocytes. J. Neurosci. Res., 31, 14-20.
2. Balaban, C.D. (1985) Central neurotoxic effects of intraperitoneally administered 3-acetylpyridine, harmaline and niacinamide in Sprague-Dawley and Long-Evans rats: a critical review of central 3-acetylpyridine neurotoxicity. Brain Res. Rev., 9, 21-42.
3. Benowitz, L.I. & Routtenberg, A. (1997) GAP-43: an intrinsic determinant of neuronal development and plasticity. Trends Neurosci., 20, 84-91.
4. Busiguina, S., Chowen, J., Argente, J. & Torres-Aleman, I. (1996) Specific alterations of the insulin like growth factor I system in the cerebellum of diabetic rats. Endocrinology, 137, 4980-4987.
5. Butterworth, R.F. (1992) Animal models of the cerebellar ataxias. In Boulton, A., Baker, G. & Butterworth, R.F. (eds.), Neuromethods, Vol. 21. Humana Press, New Jersey, pp. 275-294.
6. Chen, D.F., Schneider, G.E., Martinou, J.C. & Tonegawa, S. (1997) Bcl-2 promotes regeneration of severed axons in mammalian CNS. Nature, 385, 434-439.
7. Cheng, B. & Mattson, M.P. (1992) IGF-I and IGF-II protect cultured hippocampal and septal neurons against calcium-mediated hypoglycemic damage. J. Neurosci., 12, 1558-1566.
8. Clark, R.S.B., Chen, J., Watkins, S.C., Kochanek, P.M., Chen, M, Stetler, R.A., Loeffert, J.E. & Graham, S.H. (1997) Apoptosis-suppiessor gene bcl-2 expression after traumatic brain injury in rats. J. Neurosci., 17, 9172-9182.
9. Contreras, P.C., Vaught, J.L., Gruner, J.A., Brosnan, C., Steffler, C., Arezzo, J.C., Lewis, M.E., Kessler, J.A. & Apfel, S.C. (1997) Insulin-like growth factor I prevents development of a vincristine neuropathy in mice. Brain Res., 774, 20-26.
10. D'Mello, S.R., Galli, C., Ciotti, T. & Calissano, P. (1993) Induction of apoptosis in cerebellar granule neurons by low potassium: inhibition of death by insulin-like growth factor I and cAMP. Proc. Natl Acad. Sci. USA, 90, 10989-10993.
11. Donovan, S.M., Youngman, O., Hung, P. & Rosenfeld, R.G. (1989) Ontogeny of serum insulin-like growth factor binding proteins in the rat. Endocrinology, 125, 2621-2627.
12. Dore, S., Kar, S. & Quirion, R. (1997a) Rediscovering an old friend, IGF-I: potential use in the treatment of neurodegenerative diseases. Trends Neurosci., 20, 326-331.